These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2903110

  • 1. Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis.
    Mulder CJ, Tytgat GN, Weterman IT, Dekker W, Blok P, Schrijver M, van der Heide H.
    Gastroenterology; 1988 Dec; 95(6):1449-53. PubMed ID: 2903110
    [Abstract] [Full Text] [Related]

  • 2. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG, Macdonald JK.
    Cochrane Database Syst Rev; 2012 Oct 17; 10():CD000543. PubMed ID: 23076889
    [Abstract] [Full Text] [Related]

  • 3. An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group.
    Ann Intern Med; 1996 Jan 15; 124(2):204-11. PubMed ID: 8533995
    [Abstract] [Full Text] [Related]

  • 4. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
    Rachmilewitz D.
    BMJ; 1989 Jan 14; 298(6666):82-6. PubMed ID: 2563951
    [Abstract] [Full Text] [Related]

  • 5. Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group.
    Hanauer S, Schwartz J, Robinson M, Roufail W, Arora S, Cello J, Safdi M.
    Am J Gastroenterol; 1993 Aug 14; 88(8):1188-97. PubMed ID: 8338086
    [Abstract] [Full Text] [Related]

  • 6. Comparison of delayed-release 5-aminosalicylic acid (mesalazine) and sulfasalazine as maintenance treatment for patients with ulcerative colitis.
    Riley SA, Mani V, Goodman MJ, Herd ME, Dutt S, Turnberg LA.
    Gastroenterology; 1988 Jun 14; 94(6):1383-9. PubMed ID: 2896139
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.
    Miner P, Hanauer S, Robinson M, Schwartz J, Arora S.
    Dig Dis Sci; 1995 Feb 14; 40(2):296-304. PubMed ID: 7851193
    [Abstract] [Full Text] [Related]

  • 8. Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid.
    Dew MJ, Hughes P, Harries AD, Williams G, Evans BK, Rhodes J.
    Br Med J (Clin Res Ed); 1982 Oct 09; 285(6347):1012. PubMed ID: 6127137
    [No Abstract] [Full Text] [Related]

  • 9. Comparable efficacy of oral 5-aminosalicylic acid (Mesasal) and sulfasalazine in maintaining ulcerative colitis in remission.
    Eliakim R, Wengrower D, Ligumsky M, Rachmilewitz D.
    Isr J Med Sci; 1990 Jan 09; 26(1):47-9. PubMed ID: 1968895
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine.
    Habal FM, Greenberg GR.
    Am J Gastroenterol; 1988 Jan 09; 83(1):15-9. PubMed ID: 2892391
    [Abstract] [Full Text] [Related]

  • 11. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis.
    Sutherland LR, May GR, Shaffer EA.
    Ann Intern Med; 1993 Apr 01; 118(7):540-9. PubMed ID: 8095128
    [Abstract] [Full Text] [Related]

  • 12. Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study.
    Sninsky CA, Cort DH, Shanahan F, Powers BJ, Sessions JT, Pruitt RE, Jacobs WH, Lo SK, Targan SR, Cerda JJ.
    Ann Intern Med; 1991 Sep 01; 115(5):350-5. PubMed ID: 1863024
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Coated oral 5-aminosalicylic acid (Claversal) is equivalent to sulfasalazine for remission maintenance in ulcerative colitis. A double-blind study.
    Ardizzone S, Petrillo M, Molteni P, Desideri S, Bianchi Porro G.
    J Clin Gastroenterol; 1995 Dec 01; 21(4):287-9. PubMed ID: 8583101
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 5-Aminosalicylic acid enemas: effective agent in maintaining remission in left-sided ulcerative colitis.
    Biddle WL, Greenberger NJ, Swan JT, McPhee MS, Miner PB.
    Gastroenterology; 1988 Apr 01; 94(4):1075-9. PubMed ID: 3278942
    [Abstract] [Full Text] [Related]

  • 17. Intermittent therapy with high-dose 5-aminosalicylic acid enemas for maintaining remission in ulcerative proctosigmoiditis.
    d'Albasio G, Trallori G, Ghetti A, Milla M, Nucci A, Pacini F, Morettini A.
    Dis Colon Rectum; 1990 May 01; 33(5):394-7. PubMed ID: 1970284
    [Abstract] [Full Text] [Related]

  • 18. Bioavailability of 5-aminosalicyclic acid from slow release 5-aminosalicyclic acid drug and sulfasalazine in normal children.
    Christensen LA, Fallingborg J, Jacobsen BA, Abildgaard K, Rasmussen HH, Rasmussen SN, Hansen SH.
    Dig Dis Sci; 1993 Oct 01; 38(10):1831-6. PubMed ID: 8104772
    [Abstract] [Full Text] [Related]

  • 19. Double-blind comparative study of sulfasalazine and controlled-release mesalazine tablets in the treatment of active ulcerative colitis.
    Munakata A, Yoshida Y, Muto T, Tsuchiya S, Fukushima T, Hiwatashi N, Kobayashi K, Kitano A, Shimoyama T, Inoue M.
    J Gastroenterol; 1995 Nov 01; 30 Suppl 8():108-11. PubMed ID: 8563868
    [Abstract] [Full Text] [Related]

  • 20. Comparison of delayed release 5 aminosalicylic acid (mesalazine) and sulphasalazine in the treatment of mild to moderate ulcerative colitis relapse.
    Riley SA, Mani V, Goodman MJ, Herd ME, Dutt S, Turnberg LA.
    Gut; 1988 May 01; 29(5):669-74. PubMed ID: 2899536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.